CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)
$24.95 -0.65 (-2.5391%)
Analysed CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) News Sources
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
10-04-2026
yahoo.com
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
10-04-2026
yahoo.com
If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now
10-04-2026
yahoo.com
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
09-04-2026
yahoo.com
Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why
09-04-2026
yahoo.com
Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
08-04-2026
yahoo.com
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
08-04-2026
yahoo.com
SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema
07-04-2026
yahoo.com
AMGN's Subcutaneous Tepezza Scores Phase III Win in Thyroid Eye Disease
07-04-2026
yahoo.com
IBRX Responds to FDA Warning Over Misleading Cancer Drug Claims
07-04-2026
yahoo.com
What is the current price of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The current price of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is $24.95.
CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) since the previous trading day is $-0.65.
CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) since the previous trading day is -2.5391%.
What is the most recent average sentiment score for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The most recent average sentiment score for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The most recent sentiment for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is .
SEC-8K** Filing Available For CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.